HPV persistence after cervical surgical excision of high-grade cervical lesions

Affiliations

¹ Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
² Gynecological Oncology Unit, Centro di Riferimento Oncologico-National Cancer Institute, Aviano, Italy.
³ Woman's Health Sciences Department, Gynecologic Section, Polytechnic University of Marche, Ancona, Italy.
⁴ Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
⁵ Gynaecology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁶ Department of Obstetrics and Gynecology, "Filippo Del Ponte" Hospital, University of Insubria, Varese, Italy.
⁷ Ospedale di Circolo Fondazione Macchi, Varese, Italy.
⁸ UOC Ginecologia Oncologica, Dipartimento per la Salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
⁹ Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.

Free article

Giorgio Bogani et al. Cancer Cytopathol. 2024 May.

Free article

. 2024 May;132(5):268-269.

doi: 10.1002/cncy.22760. Epub 2023 Sep 25.

¹ Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
² Gynecological Oncology Unit, Centro di Riferimento Oncologico-National Cancer Institute, Aviano, Italy.
³ Woman's Health Sciences Department, Gynecologic Section, Polytechnic University of Marche, Ancona, Italy.
⁴ Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
⁵ Gynaecology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁶ Department of Obstetrics and Gynecology, "Filippo Del Ponte" Hospital, University of Insubria, Varese, Italy.
⁷ Ospedale di Circolo Fondazione Macchi, Varese, Italy.
⁸ UOC Ginecologia Oncologica, Dipartimento per la Salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
⁹ Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.

No abstract available

Keywords: HPV; HPV persistence; cervical cancer; cervical dysplasia; duration.

References

1. Mix J, Saraiya M, Hallowell BD, et al. Cervical precancers and cancers attributed to HPV types by race and ethnicity: implications for vaccination, screening, and management. J Natl Cancer Inst. 2022;114(6):djac034‐853. doi:10.1093/jnci/djac034
1. Egemen D, Cheung LC, Chen X, et al. Risk estimates supporting the 2019 ASCCP Risk‐Based Management Consensus Guidelines. J Low Genit Tract Dis. 2020;24(2):132‐143. doi:10.1097/LGT.0000000000000529
1. Bogani G, Sopracordevole F, Ciavattini A, et al. Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia. Eur J Cancer Prev. 2023. doi:10.1097/CEJ.0000000000000822
1. Nichols AC, Faquin WC, Westra WH, et al. HPV‐16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009;140(2):228‐234. doi:10.1016/j.otohns.2008.11.025
1. Leshchiner I, Mroz EA, Cha J, et al. Inferring early genetic progression in cancers with unobtainable premalignant disease. Nat Cancer. 2023;4(4):550‐563. doi:10.1038/s43018‐023‐00533‐y